CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Conditions:   Kidney Transplant;   Kidney Failure;   Highly Sensitized Interventions:   Drug: Cyclophosphamide;   Biological: CART-BCMA;   Biological: huCART19;   Drug: Fludarabine Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials